<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39404379</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>A Gain-of-Function Cleavage of TonEBP by Coronavirus NSP5 to Suppress IFN-β Expression.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1614</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells13191614</ELocationID><Abstract><AbstractText>Human coronaviruses (HCoVs) modify host proteins to evade the antiviral defense and sustain viral expansion. Here, we report tonicity-responsive enhancer (TonE) binding protein (TonEBP) as a cellular target of HCoVs. TonEBP was cleaved into N-terminal and C-terminal fragments (TonEBP NT and TonEBP CT, respectively) by NSP5 from all the HCoVs tested. This cleavage resulted in the loss of TonEBP's ability to stimulate the TonE-driven transcription. On the other hand, TonEBP NT promoted viral expansion in association with the suppression of <i>IFN-β</i> expression. TonEBP NT competed away NF-κB binding to the PRD II domain on the <i>IFN-β</i> promoter. A TonEBP mutant resistant to the cleavage by NSP5 did not promote the viral expansion nor suppress the <i>IFN-β</i> expression. These results demonstrate that HCoVs use a common strategy of targeting TonEBP to suppress the host immune defense.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Hyun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sang Min</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0009-0004-1182-5320</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeong</LastName><ForeName>Su Ji</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0003-2611-6792</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kweon</LastName><ForeName>Yeong Cheon</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Go Woon</ForeName><Initials>GW</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Whi Young</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee-Kwon</LastName><ForeName>Whaseon</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Chan Young</ForeName><Initials>CY</Initials><Identifier Source="ORCID">0000-0002-5183-3665</Identifier><AffiliationInfo><Affiliation>Biomedical Engineering, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Hyug Moo</ForeName><Initials>HM</Initials><Identifier Source="ORCID">0000-0003-3244-2025</Identifier><AffiliationInfo><Affiliation>Department of Biological Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2018R1A5A1024340</GrantID><Agency>National Research Foundation of Korea</Agency><Country /></Grant><Grant><GrantID>2022R1A2C3006522</GrantID><Agency>National Research Foundation of Korea</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>77238-31-4</RegistryNumber><NameOfSubstance UI="D016899">Interferon-beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016899" MajorTopicYN="Y">Interferon-beta</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017934" MajorTopicYN="N">Coronavirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">IFN-β promoter</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">gain of function</Keyword><Keyword MajorTopicYN="N">innate immunity</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>16</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>9</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39404379</ArticleId><ArticleId IdType="pmc">PMC11476177</ArticleId><ArticleId IdType="doi">10.3390/cells13191614</ArticleId><ArticleId IdType="pii">cells13191614</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schoeman D., Fielding B.C. Coronavirus envelope protein: Current knowledge. Virol. J. 2019;16:69. doi: 10.1186/s12985-019-1182-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-019-1182-0</ArticleId><ArticleId IdType="pmc">PMC6537279</ArticleId><ArticleId IdType="pubmed">31133031</ArticleId></ArticleIdList></Reference><Reference><Citation>Fielding B.C. Human coronavirus NL63: A clinically important virus? Future Microbiol. 2011;6:153–159. doi: 10.2217/fmb.10.166.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.10.166</ArticleId><ArticleId IdType="pmc">PMC7079714</ArticleId><ArticleId IdType="pubmed">21366416</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner S., Kratzel A., Barut G.T., Lang R.M., Aguiar Moreira E., Thomann L., Kelly J.N., Thiel V. SARS-CoV-2 biology and host interactions. Nat. Rev. Microbiol. 2024;22:206–225. doi: 10.1038/s41579-023-01003-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-023-01003-z</ArticleId><ArticleId IdType="pubmed">38225365</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavan M., Moro S. Lessons Learnt from COVID-19: Computational Strategies for Facing Present and Future Pandemics. Int. J. Mol. Sci. 2023;24:4401. doi: 10.3390/ijms24054401.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24054401</ArticleId><ArticleId IdType="pmc">PMC10003049</ArticleId><ArticleId IdType="pubmed">36901832</ArticleId></ArticleIdList></Reference><Reference><Citation>Carabelli A.M., Peacock T.P., Thorne L.G., Harvey W.T., Hughes J., Consortium C.-G.U., Peacock S.J., Barclay W.S., de Silva T.I., Towers G.J., et al. SARS-CoV-2 variant biology: Immune escape, transmission and fitness. Nat. Rev. Microbiol. 2023;21:162–177. doi: 10.1038/s41579-022-00841-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00841-7</ArticleId><ArticleId IdType="pmc">PMC9847462</ArticleId><ArticleId IdType="pubmed">36653446</ArticleId></ArticleIdList></Reference><Reference><Citation>Minkoff J.M., tenOever B. Innate immune evasion strategies of SARS-CoV-2. Nat. Rev. Microbiol. 2023;21:178–194. doi: 10.1038/s41579-022-00839-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00839-1</ArticleId><ArticleId IdType="pmc">PMC9838430</ArticleId><ArticleId IdType="pubmed">36631691</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X., Riva L., Pu Y., Martin-Sancho L., Kanamune J., Yamamoto Y., Sakai K., Gotoh S., Miorin L., De Jesus P.D., et al. MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells. Cell Rep. 2021;34:108628. doi: 10.1016/j.celrep.2020.108628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108628</ArticleId><ArticleId IdType="pmc">PMC7832566</ArticleId><ArticleId IdType="pubmed">33440148</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazear H.M., Schoggins J.W., Diamond M.S. Shared and Distinct Functions of Type I and Type III Interferons. Immunity. 2019;50:907–923. doi: 10.1016/j.immuni.2019.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.03.025</ArticleId><ArticleId IdType="pmc">PMC6839410</ArticleId><ArticleId IdType="pubmed">30995506</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubel P., Urban C., Bergant V., Schneider W.M., Knauer B., Stukalov A., Scaturro P., Mann A., Brunotte L., Hoffmann H.H., et al. A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape. Nat. Immunol. 2019;20:493–502. doi: 10.1038/s41590-019-0323-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-019-0323-3</ArticleId><ArticleId IdType="pubmed">30833792</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Qin C., Rao Y., Ngo C., Feng J.J., Zhao J., Zhang S., Wang T.Y., Carriere J., Savas A.C., et al. SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response. mBio. 2021;12:e0233521. doi: 10.1128/mBio.02335-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02335-21</ArticleId><ArticleId IdType="pmc">PMC8546575</ArticleId><ArticleId IdType="pubmed">34544279</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W., Gu M., Zhu L., Yan Z., Schenten D., Herrick S., Li H., Samrat S.K., Zhu J., Chen Y. The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression. Signal Transduct. Target. Ther. 2023;8:162. doi: 10.1038/s41392-023-01418-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01418-3</ArticleId><ArticleId IdType="pmc">PMC10098221</ArticleId><ArticleId IdType="pubmed">37055405</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Li Z., Guo J., Xu S., Zhou J., Chen Q., Tong X., Wang D., Peng G., Fang L., et al. SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog. J. Virol. 2022;96:e0003722. doi: 10.1128/jvi.00037-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00037-22</ArticleId><ArticleId IdType="pmc">PMC9044939</ArticleId><ArticleId IdType="pubmed">35389264</ArticleId></ArticleIdList></Reference><Reference><Citation>Planès R., Pinilla M., Santoni K., Hessel A., Passemar C., Lay K., Paillette P., Valadao A.L.C., Robinson K.S., Bastard P., et al. Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells. Mol. Cell. 2022;82:2385–2400. doi: 10.1016/j.molcel.2022.04.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2022.04.033</ArticleId><ArticleId IdType="pmc">PMC9108100</ArticleId><ArticleId IdType="pubmed">35594856</ArticleId></ArticleIdList></Reference><Reference><Citation>Moustaqil M., Ollivier E., Chiu H.P., Van Tol S., Rudolffi-Soto P., Stevens C., Bhumkar A., Hunter D.J.B., Freiberg A.N., Jacques D., et al. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): Implications for disease presentation across species. Emerg. Microbes Infect. 2021;10:178–195. doi: 10.1080/22221751.2020.1870414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1870414</ArticleId><ArticleId IdType="pmc">PMC7850364</ArticleId><ArticleId IdType="pubmed">33372854</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyakawa H., Woo S.K., Dahl S.C., Handler J.S., Kwon H.M. Tonicity-responsive enhancer binding protein, a rel-like protein that stimulates transcription in response to hypertonicity. Proc. Natl. Acad. Sci. USA. 1999;96:2538–2542. doi: 10.1073/pnas.96.5.2538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.5.2538</ArticleId><ArticleId IdType="pmc">PMC26820</ArticleId><ArticleId IdType="pubmed">10051678</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu Y., Ye X., Zhang H.M., Hanson P., Zhao G., Tong L., Xie R., Yang D. Cleavage of osmosensitive transcriptional factor NFAT5 by Coxsackieviral protease 2A promotes viral replication. PLoS Pathog. 2017;13:e1006744. doi: 10.1371/journal.ppat.1006744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006744</ArticleId><ArticleId IdType="pmc">PMC5738146</ArticleId><ArticleId IdType="pubmed">29220410</ArticleId></ArticleIdList></Reference><Reference><Citation>Huerga Encabo H., Traveset L., Argilaguet J., Angulo A., Nistal-Villan E., Jaiswal R., Escalante C.R., Gekas C., Meyerhans A., Aramburu J., et al. The transcription factor NFAT5 limits infection-induced type I interferon responses. J. Exp. Med. 2020;217:jem.20190449. doi: 10.1084/jem.20190449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20190449</ArticleId><ArticleId IdType="pmc">PMC7062515</ArticleId><ArticleId IdType="pubmed">31816635</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee A.R., Kweon Y.C., Lee S.M., Park C.Y. Human coronavirus 3CL proteases cleave septins and disrupt Hedgehog signaling, causing ciliary dysfunction. J. Med. Virol. 2023;95:e28618. doi: 10.1002/jmv.28618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28618</ArticleId><ArticleId IdType="pubmed">36840410</ArticleId></ArticleIdList></Reference><Reference><Citation>Roe M.K., Junod N.A., Young A.R., Beachboard D.C., Stobart C.C. Targeting novel structural and functional features of coronavirus protease nsp5 (3CL(pro), M(pro)) in the age of COVID-19. J. Gen. Virol. 2021;102:001558. doi: 10.1099/jgv.0.001558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.001558</ArticleId><ArticleId IdType="pmc">PMC8515871</ArticleId><ArticleId IdType="pubmed">33507143</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.D., Colla E., Sheen M.R., Na K.Y., Kwon H.M. Multiple domains of TonEBP cooperate to stimulate transcription in response to hypertonicity. J. Biol. Chem. 2003;278:47571–47577. doi: 10.1074/jbc.M308795200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M308795200</ArticleId><ArticleId IdType="pubmed">12970349</ArticleId></ArticleIdList></Reference><Reference><Citation>Saura M., Zaragoza C., McMillan A., Quick R.A., Hohenadl C., Lowenstein J.M., Lowenstein C.J. An antiviral mechanism of nitric oxide: Inhibition of a viral protease. Immunity. 1999;10:21–28. doi: 10.1016/S1074-7613(00)80003-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-7613(00)80003-5</ArticleId><ArticleId IdType="pmc">PMC7129050</ArticleId><ArticleId IdType="pubmed">10023767</ArticleId></ArticleIdList></Reference><Reference><Citation>Deonarain R., Cerullo D., Fuse K., Liu P.P., Fish E.N. Protective role for interferon-beta in coxsackievirus B3 infection. Circulation. 2004;110:3540–3543. doi: 10.1161/01.CIR.0000136824.73458.20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000136824.73458.20</ArticleId><ArticleId IdType="pubmed">15249500</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>